We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$1.08B
(+21%)
Cap. Flow
+$404M
Cap. Flow
% of AUM
6.55%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$197M |
| 2 |
AGN
Allergan plc
AGN
|
+$135M |
| 3 |
Bausch Health
BHC
|
+$129M |
| 4 |
CVS Health
CVS
|
+$107M |
| 5 |
McKesson
MCK
|
+$94.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$286M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$225M |
| 3 |
Gilead Sciences
GILD
|
+$86.1M |
| 4 |
Perrigo
PRGO
|
+$79.4M |
| 5 |
Cardinal Health
CAH
|
+$74.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.16% |
| 2 | Consumer Discretionary | 5.06% |
| 3 | Energy | 4.01% |
| 4 | Utilities | 3.23% |
| 5 | Financials | 3.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPWR
701
DELISTED
SunPower Corporation Common Stock
SPWR
| $269K | ﹤0.01% |
12,686
-1,564
| -11% | -$33.4K |
|
702
Abercrombie & Fitch
ANF
$4.42B
| $268K | ﹤0.01% |
+6,937
| New | +$254K |
|
|
GG
703
DELISTED
Goldcorp Inc
GG
| $267K | ﹤0.01% |
+10,900
| New | +$277K |
|
704
Kimco Realty
KIM
$17.2B
| $264K | ﹤0.01% |
12,049
-1,193
| -9% | -$25.4K |
|
705
Macy's
M
$6.53B
| $264K | ﹤0.01% |
4,447
-5,073
| -53% | -$282K |
|
|
AZPN
706
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $264K | ﹤0.01% |
+6,231
| New | +$264K |
|
707
Global Payments
GPN
$23B
| $261K | ﹤0.01% |
+7,326
| New | +$252K |
|
708
MSCI
MSCI
$41.6B
| $261K | ﹤0.01% |
6,052
-655
| -10% | -$28.6K |
|
|
AVP
709
DELISTED
Avon Products, Inc.
AVP
| $261K | ﹤0.01% |
17,772
-3,538,601
| -100% | -$54.4M |
|
710
Popular Inc
BPOP
$11.2B
| $260K | ﹤0.01% |
+8,370
| New | +$238K |
|
711
Groupon
GRPN
$1.05B
| $259K | ﹤0.01% |
1,646
-551
| -25% | -$107K |
|
712
PENN Entertainment
PENN
$2.75B
| $259K | ﹤0.01% |
+21,015
| New | +$259K |
|
713
Church & Dwight Co
CHD
$23.4B
| $257K | ﹤0.01% |
+7,428
| New | +$246K |
|
714
Vipshop
VIPS
$7.37B
| $257K | ﹤0.01% |
+17,210
| New | +$205K |
|
|
RKT
715
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $256K | ﹤0.01% |
4,838
-560
| -10% | -$29.3K |
|
716
KB Home
KBH
$3.37B
| $254K | ﹤0.01% |
14,900
-17,438
| -54% | -$320K |
|
|
SWC
717
DELISTED
Stillwater Mining Co
SWC
| $253K | ﹤0.01% |
+17,070
| New | +$232K |
|
718
United Bankshares
UBSI
$6.63B
| $252K | ﹤0.01% |
+8,212
| New | +$246K |
|
|
DF
719
DELISTED
Dean Foods Company
DF
| $252K | ﹤0.01% |
16,281
-318,006
| -95% | -$4.95M |
|
720
O'Reilly Automotive
ORLY
$72.9B
| $251K | ﹤0.01% |
+25,350
| New | +$242K |
|
721
Phillips 66
PSX
$84.9B
| $251K | ﹤0.01% |
3,245
-24,316
| -88% | -$1.85M |
|
|
ANDV
722
DELISTED
Andeavor
ANDV
| $250K | ﹤0.01% |
4,927
-44,988
| -90% | -$2.34M |
|
723
Dollar General
DG
$28B
| $247K | ﹤0.01% |
4,435
-10,529
| -70% | -$613K |
|
724
Jacobs Solutions
J
$15.9B
| $247K | ﹤0.01% |
4,696
-5,338
| -53% | -$275K |
|
725
CarMax
KMX
$8.13B
| $247K | ﹤0.01% |
5,265
-36,183
| -87% | -$1.69M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q1 2014 Portfolio in Review
As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.
- Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
- Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
- Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
- Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
- Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
- Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
- Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.
Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.